RxDoctor Payments Data

Rebecca Olander

Psychiatric/Mental Health · Lincoln, NENPI 1174762405

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 407 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,839in general payments, 2019–2025

Across 407 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Supernus Pharmaceuticals, Inc.$1K
  • Otsuka America Pharmaceutical, Inc.$788
  • Tris Pharma Inc$683
  • Lundbeck LLC$474
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$456
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$6,839100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,839 in reported general payments places this provider in the 90th percentile of 255 psychiatric/mental health providers in Nebraska.

See all psychiatric/mental health providers in Nebraska

Medicare billing

Part B allowed, 2024
$3,940
Medicare patients
12
Services billed
42

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Quetiapine Fumarate ErQuetiapine Fumarate13$1,116
Oxcarbazepine13$742
Risperidone64$676
Sertraline Hcl32$589
Hydroxyzine Hcl14$562
Lamotrigine21$500
Duloxetine Hcl16$496
Lorazepam27$300
Escitalopram Oxalate30$294
Bupropion XlBupropion Hcl11$264
Quetiapine Fumarate18$260
Aripiprazole14$186
Zolpidem Tartrate ErZolpidem Tartrate14$112
Alprazolam13$69

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →